J. Kulstad

发表

P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease

S. Asthana, S. Plymate, S. Craft, 2004, Neurobiology of Aging.

Peripheral Amyloid-β Levels Regulate Amyloid-β Clearance from the Central Nervous System

S. Craft, C. Savard, S. Lee, 2011 .

Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.

S. Craft, G. Watson, C. Savard, 2009, Journal of Alzheimer's disease : JAD.

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

M. Reger, S. Asthana, S. Plymate, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

S. Craft, J. Leverenz, P. McMillan, 2006, Experimental Neurology.

Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque

P. Mehta, E. Peskind, S. Craft, 2005, Journal of neuropathology and experimental neurology.

Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome

Subramaniam Pennathur, S. Pennathur, J. Brunzell, 2008, Circulation.

Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease

M. Reger, P. Mehta, S. Asthana, 2006, Neurology.

Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

G. Schellenberg, S. Craft, R. Roth, 2003 .

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study

M. Reger, S. Asthana, S. Plymate, 2005 .

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.

T. Montine, S. Asthana, E. Peskind, 2005, Archives of neurology.

O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD

S. Asthana, S. Plymate, S. Craft, 2004, Neurobiology of Aging.

Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer’s Disease Is Associated with the Apolipoprotein E- (cid:1) 4 Allele

G. Schellenberg, S. Craft, R. Roth, 2002 .

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

K. Kovacina, P. McMillan, J. Kulstad, 2003, The American journal of pathology.